美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP

10.13

0.0000

盤後：10.130.00000.00%16:10 EDT

成交量：10

成交額：102

市值：4.68億

市盈率：- -

高：10.13

開：10.13

低：10.13

收：10.13

52周最高：10.22

52周最低：9.96

股本：4,618.62萬

流通股本：4,115.50萬

量比：0.00

換手率：0.00%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

禮來(LLY.US)三靶點激動劑公布III期數據

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/GCGR/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GCGR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GCGR\",,,,,undefined,":{"symbol":"GCGR","market":"US","secType":"STK","nameCN":"GENERAL CATALYST GLOBAL RESILIENCE MERGER CORP","latestPrice":10.131,"timestamp":1791489600000,"preClose":10.131,"halted":0,"volume":10,"hourTrading":{"tag":"盘后","latestPrice":10.131,"preClose":10.131,"latestTime":"16:10 EDT","volume":2,"amount":20.16,"timestamp":1791490204165,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0,"floatShares":41155000,"shares":46186200,"eps":0,"marketStatus":"已收盤","change":0,"latestTime":"10-08 16:00:00 EDT","open":10.131,"high":10.131,"low":10.131,"amount":102,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1791532800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":10.131,"postHourTrading":{"tag":"盘后","latestPrice":10.131,"preClose":10.131,"latestTime":"16:10 EDT","volume":2,"amount":20.16,"timestamp":1791490204165,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.00016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GCGR\",,,,,undefined,":{"symbol":"GCGR","floatShares":41155000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.00016,"shares":46186200,"dividePrice":0,"high":10.131,"amplitude":0,"preClose":10.131,"low":10.131,"week52Low":9.96,"pbRate":"--","week52High":10.22,"institutionHeld":0,"latestPrice":10.131,"eps":0,"divideRate":0,"volume":10,"delay":0,"ttmEps":0,"open":10.131,"prevYearClose":10.07,"prevWeekClose":10.13,"prevMonthClose":10.12,"prevQuarterClose":10.12,"fiveDayClose":10.135,"twentyDayClose":10.19,"sixtyDayClose":10.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GCGR\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GCGR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GCGR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GCGR\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671427645","title":"禮來(LLY.US)三靶點激動劑公布III期數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2671427645","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671427645?lang=zh_tw&edition=fundamental","pubTime":"2026-09-30 15:19","pubTimestamp":1790752761,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，9月30日，礼来公布TRIUMPH-2研究的详细结果。TRIUMPH-2是一项III期临床研究，旨在在合并有2型糖尿病的肥胖或超重成人患者中评估retatrutide的有效性和安全性。Retatrutide是目前进展最快的GLP-1R/GIPR/GCGR激动剂。礼来计划于2027年第一季度向美国食品药品监督管理局提交生物制品许可申请。TRIUMPH-2研究中阻塞性睡眠呼吸暂停试验的更多研究结果将在未来的医学会议上公布，并发表于同行评议期刊。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502585.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GIPR","BK4160","GCGR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}